市場調査レポート

商品コード

1453906

バチルスコアグランスの2030年までの市場予測：製品タイプ、形態、流通チャネル、用途、エンドユーザー、地域別の世界分析

Bacillus Coagulans Market Forecasts to 2030 - Global Analysis By Product Type (Animal-Based and Plant-Based), Form (Spore, Liquid and Powder), Distribution Channel, Application, End User and By Geography

出版日: 2024年03月03日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 617,935円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 781,725円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 945,515円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,116,750円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.90円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、バチルスコアグランスの世界市場は2023年に1億300万米ドルを占め、予測期間中にCAGR 10.1％で成長し、2030年には2億200万米ドルに達すると予想されています。

Bacillus coagulansは、消化器系の健康を促進し、免疫機能をサポートする能力により、一般的にプロバイオティクスとして使用される有益な細菌です。これは、熱、酸性、胆汁酸塩などの過酷な条件に耐えることができる芽胞形成、乳酸産生細菌であり、それは非常に弾力性と栄養補助食品として効果的です。有胞子性乳酸菌は、有害な細菌の増殖を抑制し、有益な細菌の増殖を促進することにより、腸内細菌叢の健康的なバランスを維持するのに役立ちます。

プロバイオティクスの拡大

プロバイオティクスは、その潜在的な健康効果、特に消化器系の健康と免疫機能のサポートにより、大きな注目を集めています。プロバイオティクス細菌として、バチルスコアグランスはこの市場動向の拡大から恩恵を受けています。さらに、ヘルスケア専門家や研究者は、科学的研究や臨床試験を通じて、バチルスコアグランスを含むプロバイオティクスの利点を積極的に推進してきました。これらの研究から得られた肯定的な知見は、プロバイオティクスが実行可能な健康ソリューションとして信頼され、受け入れられることに貢献し、市場の拡大をさらに後押ししています。

製品の安定性

バチルスコアグランスは生きた細菌であり、温度、湿気、酸素への暴露など、さまざまな環境要因に敏感です。しかし、バチルスコアグランスは、pHレベル、栄養の利用可能性、他の成分との適合性など、最適な成長と生存のための特定の要件を持っている場合があります。製品の賞味期限を通してバチルスコアグランスの安定性と生存性を維持することは困難であり、製品の不安定性はその有効性と消費者の信頼に影響する可能性があり、市場の需要を阻害します。

消費者の意識の高まり

消費者の健康と福祉に対する意識が高まるにつれ、消化器系の健康をサポートする自然で効果的なソリューションに対する需要が高まっています。有胞子性乳酸菌は、その特性から潜在的な治療薬として注目され、消費者の意識と需要の高まりにつながっています。さらに、健康・ウェルネス関連の出版物、オンライン・リソース、ソーシャルメディア、口コミによる推奨はすべて、バチルスコアグランスの利点について消費者を啓蒙する役割を果たしています。

代替製品との競合

乳酸菌やビフィズス菌のような代替プロバイオティクス菌株は、同様の健康効果を提供し、市場でも定着しているため、競合情勢が形成されています。さらに、プレバイオティクス、シンバイオティクス、従来の医薬品などの非プロバイオティクス代替品も、同様の健康状態やウェルネス目標をターゲットとして市場シェアを争っています。確立された競合他社や代替製品の存在は、バチルスコアグランス製品の差別化と価値提案の重要性を強調し、市場の需要に影響を与えます。

COVID-19の影響

世界のバチルスコアグランス市場は、COVID-19の大流行により大きな影響を受けています。パンデミックは健康の優先順位の再評価につながり、その結果、バチルスコアグランスを含む機能性食品とプロバイオティクスの需要が増加しました。さらに、パンデミックはサプライ・チェーンに混乱を引き起こし、様々な地域における機能性食品の商業的製造に影響を与えています。

予測期間中、粉末セグメントが最大となる見込み

粉末分野は、その汎用性、利便性、様々な用途への組み込みやすさから、最大のシェアを占めると推定されます。バチルスコアグランス粉末は、プロバイオティクス細菌の濃縮形態であり、栄養補助食品、機能性食品、飼料添加物によく使用されます。さらに、バチルスコアグランスの粉末サプリメントは、消費者にプロバイオティクスを日常生活に取り入れる便利な方法を提供します。粉末は飲食品やヨーグルトに混ぜたり、食品に振りかけたりすることができ、腸の健康と免疫力を高めるシンプルでカスタマイズ可能な方法を提供します。

予測期間中、非乳製品分野のCAGRが最も高くなると予想される

非乳製品セグメントは、乳製品不使用でビーガンフレンドリーなプロバイオティクス製品に対する需要の増加により、予測期間中に有利な成長を遂げると予想されます。バチルスコアグランスは、弾力性のある芽胞形成細菌であるため、非乳製品食品や飲食品に組み込むのに適しており、プロバイオティクスに関連する健康上のメリットを得るための代替オプションを消費者に提供します。さらに、バチルスコアグランスは天然でクリーン・ラベルに適した成分として認識されることが多いため、クリーン・ラベルや天然成分を求める動向の高まりが、非乳製品プロバイオティクスの選択肢に対する需要をさらに押し上げています。

最大シェアの地域：

推定期間中、北米が最大の市場シェアを占めました。消化器系の健康とウェルネスの重要性に対する消費者の意識が高まるにつれ、バチルスコアグランスを含む製品に対する需要が高まっています。この需要の背景には、多忙なライフスタイル、食生活の乱れ、消化器疾患の増加といった要因があります。さらに、北米、特に米国とカナダの規制環境は、食品や栄養補助食品へのバチルスコアグランスの使用をサポートしており、市場の成長をさらに促進しています。

CAGRが最も高い地域：

アジア太平洋地域は、人口の多さと多様性、可処分所得の増加、健康志向の高まりにより、予測期間中に収益性の高い成長を遂げると予想されます。バチルスコアグランスは、高温と酸性環境に耐える能力を持ち、発酵プロセスに適しているため、キムチ、味噌、テンペ、漬物などのアジアの伝統食品の栄養価やプロバイオティクス含有量を高めるための人気商品となっています。さらに、この地域では胃腸障害や消化器系の健康不安が蔓延しており、腸の健康とプロバイオティクスの重要性に対する認識が高まっています。

無料のカスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場プレーヤーの包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東とアフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第11章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第12章企業プロファイル

Mitsubishi Chemical Foods Corporation
Aumgene Bioscience
Nebraska Cultures
Syngen Biotech
Sabinsa Corporation
UAS Laboratories
Ganeden
Microbax
Mystical Biotech Pvt. Ltd
Sanzyme
Synbiotics Limited
Lallemand Inc.
Bioriginal Food & Science Corp.
Unique Biotech Limited
Biovation Labs Inc.

図表

List of Tables

Table 1 Global Bacillus Coagulans Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Bacillus Coagulans Market Outlook, By Product Type (2021-2030) ($MN)
Table 3 Global Bacillus Coagulans Market Outlook, By Animal-Based (2021-2030) ($MN)
Table 4 Global Bacillus Coagulans Market Outlook, By Plant-Based (2021-2030) ($MN)
Table 5 Global Bacillus Coagulans Market Outlook, By Form (2021-2030) ($MN)
Table 6 Global Bacillus Coagulans Market Outlook, By Spore (2021-2030) ($MN)
Table 7 Global Bacillus Coagulans Market Outlook, By Liquid (2021-2030) ($MN)
Table 8 Global Bacillus Coagulans Market Outlook, By Powder (2021-2030) ($MN)
Table 9 Global Bacillus Coagulans Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 10 Global Bacillus Coagulans Market Outlook, By Offline Retail (2021-2030) ($MN)
Table 11 Global Bacillus Coagulans Market Outlook, By Online Retail (2021-2030) ($MN)
Table 12 Global Bacillus Coagulans Market Outlook, By Application (2021-2030) ($MN)
Table 13 Global Bacillus Coagulans Market Outlook, By Cereal (2021-2030) ($MN)
Table 14 Global Bacillus Coagulans Market Outlook, By Infant Nutrition (2021-2030) ($MN)
Table 15 Global Bacillus Coagulans Market Outlook, By Non-Dairy (2021-2030) ($MN)
Table 16 Global Bacillus Coagulans Market Outlook, By Probiotic Supplements (2021-2030) ($MN)
Table 17 Global Bacillus Coagulans Market Outlook, By Other Applications (2021-2030) ($MN)
Table 18 Global Bacillus Coagulans Market Outlook, By End User (2021-2030) ($MN)
Table 19 Global Bacillus Coagulans Market Outlook, By Food & Beverages (2021-2030) ($MN)
Table 20 Global Bacillus Coagulans Market Outlook, By Cosmetics (2021-2030) ($MN)
Table 21 Global Bacillus Coagulans Market Outlook, By Nutraceuticals (2021-2030) ($MN)
Table 22 Global Bacillus Coagulans Market Outlook, By Pharmaceutical (2021-2030) ($MN)
Table 23 Global Bacillus Coagulans Market Outlook, By Animal Husbandry (2021-2030) ($MN)
Table 24 Global Bacillus Coagulans Market Outlook, By Other End Users (2021-2030) ($MN)
Table 25 North America Bacillus Coagulans Market Outlook, By Country (2021-2030) ($MN)
Table 26 North America Bacillus Coagulans Market Outlook, By Product Type (2021-2030) ($MN)
Table 27 North America Bacillus Coagulans Market Outlook, By Animal-Based (2021-2030) ($MN)
Table 28 North America Bacillus Coagulans Market Outlook, By Plant-Based (2021-2030) ($MN)
Table 29 North America Bacillus Coagulans Market Outlook, By Form (2021-2030) ($MN)
Table 30 North America Bacillus Coagulans Market Outlook, By Spore (2021-2030) ($MN)
Table 31 North America Bacillus Coagulans Market Outlook, By Liquid (2021-2030) ($MN)
Table 32 North America Bacillus Coagulans Market Outlook, By Powder (2021-2030) ($MN)
Table 33 North America Bacillus Coagulans Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 34 North America Bacillus Coagulans Market Outlook, By Offline Retail (2021-2030) ($MN)
Table 35 North America Bacillus Coagulans Market Outlook, By Online Retail (2021-2030) ($MN)
Table 36 North America Bacillus Coagulans Market Outlook, By Application (2021-2030) ($MN)
Table 37 North America Bacillus Coagulans Market Outlook, By Cereal (2021-2030) ($MN)
Table 38 North America Bacillus Coagulans Market Outlook, By Infant Nutrition (2021-2030) ($MN)
Table 39 North America Bacillus Coagulans Market Outlook, By Non-Dairy (2021-2030) ($MN)
Table 40 North America Bacillus Coagulans Market Outlook, By Probiotic Supplements (2021-2030) ($MN)
Table 41 North America Bacillus Coagulans Market Outlook, By Other Applications (2021-2030) ($MN)
Table 42 North America Bacillus Coagulans Market Outlook, By End User (2021-2030) ($MN)
Table 43 North America Bacillus Coagulans Market Outlook, By Food & Beverages (2021-2030) ($MN)
Table 44 North America Bacillus Coagulans Market Outlook, By Cosmetics (2021-2030) ($MN)
Table 45 North America Bacillus Coagulans Market Outlook, By Nutraceuticals (2021-2030) ($MN)
Table 46 North America Bacillus Coagulans Market Outlook, By Pharmaceutical (2021-2030) ($MN)
Table 47 North America Bacillus Coagulans Market Outlook, By Animal Husbandry (2021-2030) ($MN)
Table 48 North America Bacillus Coagulans Market Outlook, By Other End Users (2021-2030) ($MN)
Table 49 Europe Bacillus Coagulans Market Outlook, By Country (2021-2030) ($MN)
Table 50 Europe Bacillus Coagulans Market Outlook, By Product Type (2021-2030) ($MN)
Table 51 Europe Bacillus Coagulans Market Outlook, By Animal-Based (2021-2030) ($MN)
Table 52 Europe Bacillus Coagulans Market Outlook, By Plant-Based (2021-2030) ($MN)
Table 53 Europe Bacillus Coagulans Market Outlook, By Form (2021-2030) ($MN)
Table 54 Europe Bacillus Coagulans Market Outlook, By Spore (2021-2030) ($MN)
Table 55 Europe Bacillus Coagulans Market Outlook, By Liquid (2021-2030) ($MN)
Table 56 Europe Bacillus Coagulans Market Outlook, By Powder (2021-2030) ($MN)
Table 57 Europe Bacillus Coagulans Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 58 Europe Bacillus Coagulans Market Outlook, By Offline Retail (2021-2030) ($MN)
Table 59 Europe Bacillus Coagulans Market Outlook, By Online Retail (2021-2030) ($MN)
Table 60 Europe Bacillus Coagulans Market Outlook, By Application (2021-2030) ($MN)
Table 61 Europe Bacillus Coagulans Market Outlook, By Cereal (2021-2030) ($MN)
Table 62 Europe Bacillus Coagulans Market Outlook, By Infant Nutrition (2021-2030) ($MN)
Table 63 Europe Bacillus Coagulans Market Outlook, By Non-Dairy (2021-2030) ($MN)
Table 64 Europe Bacillus Coagulans Market Outlook, By Probiotic Supplements (2021-2030) ($MN)
Table 65 Europe Bacillus Coagulans Market Outlook, By Other Applications (2021-2030) ($MN)
Table 66 Europe Bacillus Coagulans Market Outlook, By End User (2021-2030) ($MN)
Table 67 Europe Bacillus Coagulans Market Outlook, By Food & Beverages (2021-2030) ($MN)
Table 68 Europe Bacillus Coagulans Market Outlook, By Cosmetics (2021-2030) ($MN)
Table 69 Europe Bacillus Coagulans Market Outlook, By Nutraceuticals (2021-2030) ($MN)
Table 70 Europe Bacillus Coagulans Market Outlook, By Pharmaceutical (2021-2030) ($MN)
Table 71 Europe Bacillus Coagulans Market Outlook, By Animal Husbandry (2021-2030) ($MN)
Table 72 Europe Bacillus Coagulans Market Outlook, By Other End Users (2021-2030) ($MN)
Table 73 Asia Pacific Bacillus Coagulans Market Outlook, By Country (2021-2030) ($MN)
Table 74 Asia Pacific Bacillus Coagulans Market Outlook, By Product Type (2021-2030) ($MN)
Table 75 Asia Pacific Bacillus Coagulans Market Outlook, By Animal-Based (2021-2030) ($MN)
Table 76 Asia Pacific Bacillus Coagulans Market Outlook, By Plant-Based (2021-2030) ($MN)
Table 77 Asia Pacific Bacillus Coagulans Market Outlook, By Form (2021-2030) ($MN)
Table 78 Asia Pacific Bacillus Coagulans Market Outlook, By Spore (2021-2030) ($MN)
Table 79 Asia Pacific Bacillus Coagulans Market Outlook, By Liquid (2021-2030) ($MN)
Table 80 Asia Pacific Bacillus Coagulans Market Outlook, By Powder (2021-2030) ($MN)
Table 81 Asia Pacific Bacillus Coagulans Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 82 Asia Pacific Bacillus Coagulans Market Outlook, By Offline Retail (2021-2030) ($MN)
Table 83 Asia Pacific Bacillus Coagulans Market Outlook, By Online Retail (2021-2030) ($MN)
Table 84 Asia Pacific Bacillus Coagulans Market Outlook, By Application (2021-2030) ($MN)
Table 85 Asia Pacific Bacillus Coagulans Market Outlook, By Cereal (2021-2030) ($MN)
Table 86 Asia Pacific Bacillus Coagulans Market Outlook, By Infant Nutrition (2021-2030) ($MN)
Table 87 Asia Pacific Bacillus Coagulans Market Outlook, By Non-Dairy (2021-2030) ($MN)
Table 88 Asia Pacific Bacillus Coagulans Market Outlook, By Probiotic Supplements (2021-2030) ($MN)
Table 89 Asia Pacific Bacillus Coagulans Market Outlook, By Other Applications (2021-2030) ($MN)
Table 90 Asia Pacific Bacillus Coagulans Market Outlook, By End User (2021-2030) ($MN)
Table 91 Asia Pacific Bacillus Coagulans Market Outlook, By Food & Beverages (2021-2030) ($MN)
Table 92 Asia Pacific Bacillus Coagulans Market Outlook, By Cosmetics (2021-2030) ($MN)
Table 93 Asia Pacific Bacillus Coagulans Market Outlook, By Nutraceuticals (2021-2030) ($MN)
Table 94 Asia Pacific Bacillus Coagulans Market Outlook, By Pharmaceutical (2021-2030) ($MN)
Table 95 Asia Pacific Bacillus Coagulans Market Outlook, By Animal Husbandry (2021-2030) ($MN)
Table 96 Asia Pacific Bacillus Coagulans Market Outlook, By Other End Users (2021-2030) ($MN)
Table 97 South America Bacillus Coagulans Market Outlook, By Country (2021-2030) ($MN)
Table 98 South America Bacillus Coagulans Market Outlook, By Product Type (2021-2030) ($MN)
Table 99 South America Bacillus Coagulans Market Outlook, By Animal-Based (2021-2030) ($MN)
Table 100 South America Bacillus Coagulans Market Outlook, By Plant-Based (2021-2030) ($MN)
Table 101 South America Bacillus Coagulans Market Outlook, By Form (2021-2030) ($MN)
Table 102 South America Bacillus Coagulans Market Outlook, By Spore (2021-2030) ($MN)
Table 103 South America Bacillus Coagulans Market Outlook, By Liquid (2021-2030) ($MN)
Table 104 South America Bacillus Coagulans Market Outlook, By Powder (2021-2030) ($MN)
Table 105 South America Bacillus Coagulans Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 106 South America Bacillus Coagulans Market Outlook, By Offline Retail (2021-2030) ($MN)
Table 107 South America Bacillus Coagulans Market Outlook, By Online Retail (2021-2030) ($MN)
Table 108 South America Bacillus Coagulans Market Outlook, By Application (2021-2030) ($MN)
Table 109 South America Bacillus Coagulans Market Outlook, By Cereal (2021-2030) ($MN)
Table 110 South America Bacillus Coagulans Market Outlook, By Infant Nutrition (2021-2030) ($MN)
Table 111 South America Bacillus Coagulans Market Outlook, By Non-Dairy (2021-2030) ($MN)
Table 112 South America Bacillus Coagulans Market Outlook, By Probiotic Supplements (2021-2030) ($MN)
Table 113 South America Bacillus Coagulans Market Outlook, By Other Applications (2021-2030) ($MN)
Table 114 South America Bacillus Coagulans Market Outlook, By End User (2021-2030) ($MN)
Table 115 South America Bacillus Coagulans Market Outlook, By Food & Beverages (2021-2030) ($MN)
Table 116 South America Bacillus Coagulans Market Outlook, By Cosmetics (2021-2030) ($MN)
Table 117 South America Bacillus Coagulans Market Outlook, By Nutraceuticals (2021-2030) ($MN)
Table 118 South America Bacillus Coagulans Market Outlook, By Pharmaceutical (2021-2030) ($MN)
Table 119 South America Bacillus Coagulans Market Outlook, By Animal Husbandry (2021-2030) ($MN)
Table 120 South America Bacillus Coagulans Market Outlook, By Other End Users (2021-2030) ($MN)
Table 121 Middle East & Africa Bacillus Coagulans Market Outlook, By Country (2021-2030) ($MN)
Table 122 Middle East & Africa Bacillus Coagulans Market Outlook, By Product Type (2021-2030) ($MN)
Table 123 Middle East & Africa Bacillus Coagulans Market Outlook, By Animal-Based (2021-2030) ($MN)
Table 124 Middle East & Africa Bacillus Coagulans Market Outlook, By Plant-Based (2021-2030) ($MN)
Table 125 Middle East & Africa Bacillus Coagulans Market Outlook, By Form (2021-2030) ($MN)
Table 126 Middle East & Africa Bacillus Coagulans Market Outlook, By Spore (2021-2030) ($MN)
Table 127 Middle East & Africa Bacillus Coagulans Market Outlook, By Liquid (2021-2030) ($MN)
Table 128 Middle East & Africa Bacillus Coagulans Market Outlook, By Powder (2021-2030) ($MN)
Table 129 Middle East & Africa Bacillus Coagulans Market Outlook, By Distribution Channel (2021-2030) ($MN)
Table 130 Middle East & Africa Bacillus Coagulans Market Outlook, By Offline Retail (2021-2030) ($MN)
Table 131 Middle East & Africa Bacillus Coagulans Market Outlook, By Online Retail (2021-2030) ($MN)
Table 132 Middle East & Africa Bacillus Coagulans Market Outlook, By Application (2021-2030) ($MN)
Table 133 Middle East & Africa Bacillus Coagulans Market Outlook, By Cereal (2021-2030) ($MN)
Table 134 Middle East & Africa Bacillus Coagulans Market Outlook, By Infant Nutrition (2021-2030) ($MN)
Table 135 Middle East & Africa Bacillus Coagulans Market Outlook, By Non-Dairy (2021-2030) ($MN)
Table 136 Middle East & Africa Bacillus Coagulans Market Outlook, By Probiotic Supplements (2021-2030) ($MN)
Table 137 Middle East & Africa Bacillus Coagulans Market Outlook, By Other Applications (2021-2030) ($MN)
Table 138 Middle East & Africa Bacillus Coagulans Market Outlook, By End User (2021-2030) ($MN)
Table 139 Middle East & Africa Bacillus Coagulans Market Outlook, By Food & Beverages (2021-2030) ($MN)
Table 140 Middle East & Africa Bacillus Coagulans Market Outlook, By Cosmetics (2021-2030) ($MN)
Table 141 Middle East & Africa Bacillus Coagulans Market Outlook, By Nutraceuticals (2021-2030) ($MN)
Table 142 Middle East & Africa Bacillus Coagulans Market Outlook, By Pharmaceutical (2021-2030) ($MN)
Table 143 Middle East & Africa Bacillus Coagulans Market Outlook, By Animal Husbandry (2021-2030) ($MN)
Table 144 Middle East & Africa Bacillus Coagulans Market Outlook, By Other End Users (2021-2030) ($MN)

Product Code: SMRC25458

According to Stratistics MRC, the Global Bacillus Coagulans Market is accounted for $103 million in 2023 and is expected to reach $202 million by 2030 growing at a CAGR of 10.1% during the forecast period. Bacillus coagulans is a beneficial bacterium commonly used as a probiotic due to its ability to promote digestive health and support immune function. It is a spore-forming, lactic acid-producing bacterium that can survive harsh conditions such as heat, acidity, and bile salts, making it highly resilient and effective as a dietary supplement. Bacillus coagulans aids in maintaining a healthy balance of gut flora by inhibiting the growth of harmful bacteria and promoting the growth of beneficial bacteria.

Market Dynamics:

Driver:

Expansion of the probiotics

Probiotics have gained considerable attention due to their potential health benefits, particularly in supporting digestive health and immune function. As a probiotic bacterium, Bacillus coagulans has benefited from this growing market trend. Furthermore, healthcare professionals and researchers have been actively promoting the benefits of probiotics, including Bacillus coagulans, through scientific studies and clinical trials. Positive findings from these studies have contributed to the credibility and acceptance of probiotics as a viable health solution, further propelling market expansion.

Restraint:

Product stability

Bacillus coagulans is a live bacterium that is sensitive to various environmental factors, including temperature, moisture, and oxygen exposure. However, Bacillus coagulans may have specific requirements for optimal growth and survival, including pH levels, nutrient availability, and compatibility with other ingredients. Maintaining the stability and viability of Bacillus coagulans throughout the product's shelf life can be challenging, and product instability can affect its effectiveness and consumer trust, which hampers the market demand.

Opportunity:

Increasing consumer awareness

As consumers become more conscious of their health and well-being, there is a growing demand for natural and effective solutions to support digestive health. Bacillus coagulans, with its properties, has gained attention as a potential remedy, leading to increased consumer awareness and demand. Furthermore, health and wellness publications, online resources, social media, and word-of-mouth recommendations have all played a role in educating consumers about the benefits of Bacillus coagulans.

Threat:

Competition from alternative products

Alternative probiotic strains, such as Lactobacillus and Bifidobacterium species, offer similar health benefits and are well-established in the market, creating a competitive landscape. Additionally, non-probiotic alternatives, such as prebiotics, synbiotics, and conventional pharmaceuticals, compete for market share by targeting similar health conditions or wellness goals. The presence of established competitors and alternative products underscores the importance of differentiation and value proposition for Bacillus coagulans products, which impact the market demand.

Covid-19 Impact

The global Bacillus Coagulans market has experienced significant impacts due to the COVID-19 pandemic. The pandemic has led to a revaluation of health priorities, resulting in an increased demand for functional foods and probiotics, including Bacillus Coagulans. Moreover, the pandemic has caused disruptions in the supply chain, impacting the commercial manufacturing of functional food products in various regions.

The powder segment is expected to be the largest during the forecast period

The powder segment is estimated to hold the largest share, due to their versatility, convenience, and ease of incorporation into various applications. Bacillus coagulans powder is a concentrated form of the probiotic bacterium, often used in dietary supplements, functional foods, and animal feed additives. Moreover, powdered Bacillus coagulans supplements offer consumers a convenient way to incorporate probiotics into their daily routines. The powder can be easily mixed into beverages, yogurt, or sprinkled over food, providing a simple and customizable way to boost gut health and immunity.

The non-dairy segment is expected to have the highest CAGR during the forecast period

The non-dairy segment is anticipated to have lucrative growth during the forecast period, due to the increasing demand for dairy-free and vegan-friendly probiotic products. Bacillus coagulans, being a resilient spore-forming bacterium, is well-suited for incorporation into non-dairy foods and beverages, offering consumers alternative options for obtaining the health benefits associated with probiotics. Moreover, the growing trend towards clean label and natural ingredients has further fuelled the demand for non-dairy probiotic options, as Bacillus coagulans is often perceived as a natural and clean-label-friendly ingredient.

Region with largest share:

North America commanded the largest market share during the extrapolated period. With increasing awareness among consumers about the importance of digestive health and wellness, there has been a growing demand for products containing Bacillus coagulans. This demand is driven by factors such as hectic lifestyles, poor dietary habits, and rising incidences of digestive disorders. Moreover, the regulatory environment in North America, particularly in the United States and Canada, supports the use of bacillus coagulans in food and dietary supplements, further driving its market growth.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period, due to large and diverse population, increasing disposable income, and rising health consciousness. Bacillus coagulans, with its ability to withstand high temperatures and acidic environments, is well-suited for fermentation processes, making it a popular choice for enhancing the nutritional value and probiotic content of traditional Asian foods like kimchi, miso, tempeh, and pickles. Furthermore, the prevalence of gastrointestinal disorders and digestive health concerns in the region has heightened awareness of the importance of gut health and probiotics.

Key players in the market

Some of the key players in the Bacillus Coagulans Market include Mitsubishi Chemical Foods Corporation, Aumgene Bioscience, Nebraska Cultures, Syngen Biotech, Sabinsa Corporation, UAS Laboratories, Ganeden, Microbax, Mystical Biotech Pvt. Ltd, Sanzyme, Synbiotics Limited, Lallemand Inc., Bioriginal Food & Science Corp., Unique Biotech Limited and Biovation Labs Inc.

Key Developments:

In February 2024, Bioriginal Food & Science Corp. a wholly-owned subsidiary of Cooke Inc., has announced the acquisition of POS Biosciences Corp. (Saskatoon, Saskatchewan, Canada) from Canopy Growth Corp.

In October 2023, Bioriginal Food & Science Corp. has expanded into Germany with the acquisition of Pflanzenolmuhle Kroppenstedt GmbH operating as Kroppenstedter Olmuhle, a century-old, family-owned mill that specializes in the pressing of plant-based oil products from conventional and organic sources.

In August 2023, Synbiotics Limited acquired CannaCare Health GmbH with its strong CBD brand Canobo as well as the emerging CBD network marketing subsidiary WellnetIQ.

In April 2021, Mitsubishi Chemical Corporation has entered into a partnership agreement with Dymon Co., Ltd. the robot and space development venture, the first private company ever to explore the moon. Based on this agreement, MCC will provide carbon fiber reinforced plastic (CFRP) components and thermoplastic materials as well as technical support.

Product Types Covered:

Animal-Based
Plant-Based

Forms Covered:

Spore
Liquid
Powder

Distribution Channels Covered:

Offline Retail
Online Retail

Applications Covered:

Cereal
Infant Nutrition
Non-Dairy
Probiotic Supplements
Other Applications

End Users Covered:

Food & Beverages
Cosmetics
Nutraceuticals
Pharmaceutical
Animal Husbandry
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Bacillus Coagulans Market, By Product Type

5.1 Introduction
5.2 Animal-Based
5.3 Plant-Based

6 Global Bacillus Coagulans Market, By Form

6.1 Introduction
6.2 Spore
6.3 Liquid
6.4 Powder

7 Global Bacillus Coagulans Market, By Distribution Channel

7.1 Introduction
7.2 Offline Retail
7.3 Online Retail

8 Global Bacillus Coagulans Market, By Application

8.1 Introduction
8.2 Cereal
8.3 Infant Nutrition
8.4 Non-Dairy
8.5 Probiotic Supplements
8.6 Other Applications

9 Global Bacillus Coagulans Market, By End User

9.1 Introduction
9.2 Food & Beverages
9.3 Cosmetics
9.4 Nutraceuticals
9.5 Pharmaceutical
9.6 Animal Husbandry
9.7 Other End Users

10 Global Bacillus Coagulans Market, By Geography

10.1 Introduction
10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa

11 Key Developments

11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling

12.1 Mitsubishi Chemical Foods Corporation
12.2 Aumgene Bioscience
12.3 Nebraska Cultures
12.4 Syngen Biotech
12.5 Sabinsa Corporation
12.6 UAS Laboratories
12.7 Ganeden
12.8 Microbax
12.9 Mystical Biotech Pvt. Ltd
12.10 Sanzyme
12.11 Synbiotics Limited
12.12 Lallemand Inc.
12.13 Bioriginal Food & Science Corp.
12.14 Unique Biotech Limited
12.15 Biovation Labs Inc.

バチルスコアグランスの2030年までの市場予測：製品タイプ、形態、流通チャネル、用途、エンドユーザー、地域別の世界分析

Bacillus Coagulans Market Forecasts to 2030 - Global Analysis By Product Type (Animal-Based and Plant-Based), Form (Spore, Liquid and Powder), Distribution Channel, Application, End User and By Geography

最大シェアの地域：

CAGRが最も高い地域：

無料のカスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界のバチルスコアグランス市場：製品タイプ別

第6章 世界のバチルスコアグランス市場：形態別

第7章 世界のバチルスコアグランス市場：流通チャネル別

第8章 世界のバチルスコアグランス市場：用途別

第9章 世界のバチルスコアグランス市場：エンドユーザー別

第10章 世界のバチルスコアグランス市場：地域別

第11章 主な発展

第12章 企業プロファイル